We sought to determine whether the third component of complement (C3) is localized in ischemic baboon myocardium after coronary artery ligation. Furthermore, we assessed the effects of prior C3 depletion on myocardial necrosis. We studied seven control baboons (group I) and seven C3-depleted (group II) baboons that were killed 24 h after ligation of the anterior descending coronary artery. Multiple tissue samples were obtained from infarct, intermediate, and normal myocardial sites as defined by serial unipolar epicardial ECG mapping. In group I baboons, myocardial creatine kinase content from infarct sites was reduced as compared with normal sites (12.6±0.92 [SE] vs. 24.4±0.75 IU/mg protein, P < 0.001). The intermediate sites from group I contained more creatine kinase (19.0±1.25 IU/mg protein) than infarct sites (P < 0.001), but less (P < 0.025) than normal sites. In group II, intermediate sites showed no significant reduction in creatine kinase from normal sites and there was significantly less creatine kinase depletion in infarct sites when compared with group I animals (33.7±4.6 and 51.4±1.8% depletion, respectively, P < 0.001). In all seven group I baboons, uniform C3 localization was observed in infarct sites by direct immunofluorescence but appeared in mosaic patterns in intermediate sites. C3 was not demonstrated in any normal sites, nor in any site from group II baboons. Additional studies on baboons killed at earlier times after ligation indicated that C3 was localized focally on swollen myocytes in infarct sites as early as 4 h after coronary ligation. These results strongly implicate the active participation of the complement system of inflammatory proteins in the pathogenesis of myocardial tissue injury following coronary occlusion.
R. Neal Pinckard, Robert A. O'Rourke, Michael H. Crawford, Frederick S. Grover, Linda M. McManus, John J. Ghidoni, S. Brandley Storrs, Merle S. Olson
Title and authors | Publication | Year |
---|---|---|
The Role of Complement in Myocardial Infarction Reperfusion Injury: An Underappreciated Therapeutic Target
CW Vogel |
Frontiers in Cell and Developmental Biology | 2020 |
Membrane Attack Complex in Myocardial Ischemia/Reperfusion Injury: A Systematic Review for Post Mortem Applications
C Mondello, EV Spagnolo, L Cardia, D Sapienza, S Scurria, P Gualniera, A Asmundo |
Diagnostics | 2020 |
Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives
R Lordan, A Tsoupras, I Zabetakis, CA Demopoulos |
Molecules (Basel, Switzerland) | 2019 |
The effect of C-reactive protein deposition on myocardium with ischaemia–reperfusion injury in rats
SJ Oh, EN Kim, CJ Kim, JS Choi, KB Kim |
Interactive cardiovascular and thoracic surgery | 2017 |
Evaluation of the Contribution of Multiple DAMPs and DAMP Receptors in Cell Death-Induced Sterile Inflammatory Responses
H Kataoka, H Kono, Z Patel, KL Rock |
PloS one | 2014 |
Evaluation of the Contribution of Multiple DAMPs and DAMP Receptors in Cell Death-Induced Sterile Inflammatory Responses
H Kataoka, H Kono, Z Patel, KL Rock, J Kanellopoulos |
PloS one | 2014 |
Elevated C1rC1sC1inh levels independently predict atherosclerotic coronary heart disease
Z Horváth, D Csuka, K Vargova, A Kovács, AÁ Molnár, P Gulácsi-Bárdos, S Leé, L Varga, RG Kiss, I Préda, G Füst |
Molecular Immunology | 2013 |
The complement system in ischemia-reperfusion injuries
WB Gorsuch, E Chrysanthou, WJ Schwaeble, GL Stahl |
Immunobiology | 2012 |
Serum complements and heart fatty acid binding protein in Bangladeshi patients with acute myocardial infarction
N Akhtar, A Taher, R Rahman, AK Chowdhury |
Heart Asia | 2012 |
Treatment with the C5a receptor antagonist ADC-1004 reduces myocardial infarction in a porcine ischemia-reperfusion model
J der Pals, S Koul, P Andersson, M Götberg, JF Ubachs, M Kanski, H Arheden, GK Olivecrona, B Larsson, D Erlinge |
BMC Cardiovascular Disorders | 2010 |
Genetic variation in complement factor H and risk of coronary heart disease: Eight new studies and a meta-analysis of around 48,000 individuals
R Sofat, JP Casas, M Kumari, PJ Talmud, H Ireland, M Kivimaki, M Marmot, AD Hughes, S Thom, S Ebrahim, JC Whittaker, L Smeeth, DA Lawlor, SE Humphries, AD Hingorani |
Atherosclerosis | 2010 |
Atherosclerosis Disease Management
JS Suri, C Kathuria, F Molinari |
2010 | |
Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin
MN Busche, V Pavlov, K Takahashi, GL Stahl |
American journal of physiology. Heart and circulatory physiology | 2009 |
Humanized cobra venom factor decreases myocardial ischemia–reperfusion injury
WB Gorsuch, BJ Guikema, DC Fritzinger, CW Vogel, GL Stahl |
Molecular Immunology | 2009 |
Mast Cells and Basophils
GH Caughey |
Asthma and COPD | 2009 |
The mannose-binding lectin pathway is a significant contributor to reperfusion injury in the type 2 diabetic heart
LR la Bonte, B Dokken, G Davis-Gorman, GL Stahl, PF McDonagh |
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease | 2009 |
Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin
MN Busche, V Pavlov, K Takahashi, GL Stahl |
American journal of physiology. Heart and circulatory physiology | 2009 |
C-reactive protein and coronary heart disease: a critical review
JP Casas, T Shah, AD Hingorani, J Danesh, MB Pepys |
Journal of Internal Medicine | 2008 |
C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor
D Wouters, I Wagenaar-Bos, M Ham, S Zeerleder |
Expert Opinion on Biological Therapy | 2008 |
Anticomplement therapy
PA Kulkarni, V Afshar-Kharghan |
Biologics : targets & therapy | 2008 |
Mannose-binding Lectin Deficiency Offers Protection From Acute Graft Rejection After Heart Transplantation
JE Fildes, SM Shaw, AH Walker, M McAlindon, SG Williams, BG Keevil, N Yonan |
The Journal of Heart and Lung Transplantation | 2008 |
Protective role of unconjugated bilirubin on complement-mediated hepatocytolysis
CL Basiglio, SM Arriaga, HF Pelusa, AM Almará, MG Roma, AD Mottino |
Biochimica et Biophysica Acta (BBA) - General Subjects | 2007 |
Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity
J Fu, G Lin, B Zeng, Z Wu, Y Wu, H Chu, G Qin, G Liang, J Li, X Gan, X Yu, C Li, D Liu |
Biochemical and Biophysical Research Communications | 2006 |
Low levels of plasma soluble complement receptor type 1 in patients receiving thrombolytic therapy for acute myocardial infarction
G Karthikeyan, S Baalasubramanian, S Seth, N Das |
Journal of Thrombosis and Thrombolysis | 2006 |
Role of Adenosine as Adjunctive Therapy in Acute Myocardial Infarction
MB Forman, GW Stone, EK Jackson |
Cardiovascular Drug Reviews | 2006 |
Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury
Y Banz, OM Hess, SC Robson, D Mettler, P Meier, A Haeberli, E Csizmadia, EY Korchagina, NV Bovin, R Rieben |
European Heart Journal | 2005 |
Time for contrast material to traverse the epicardial artery and the myocardium in ST-Segment elevation acute myocardial infarction versus unstable angina pectoris/non–ST-elevation acute myocardial infarction
GC Wong, D Frisch, SA Murphy, MS Sabatine, R Pai, D James, N Kraimer, PT Katsiyiannis, SJ Marble, PM DiBattiste, LA Demopoulos, SG Gourlay, HV Barron, CP Cannon, CM Gibson |
The American Journal of Cardiology | 2003 |
C-reactive protein and cardiovascular disease: new insights from an old molecule
G M Hirschfield, M B Pepys |
QJM | 2003 |
C1-esterase inhibitor and a novel peptide inhibitor improve contractile function in reperfused skeletal muscle
GA Toomayan, LE Chen, HX Jiang, WN Qi, AV Seaber, MM Frank, JR Urbaniak |
Microsurgery | 2003 |
Prevention of Cardiac Cell Injury During Acute Myocardial Infarction: Possible Role for Complement Inhibition
C de Zwaan, MP van Dieijen-Visser, WT Hermens |
American Journal Cardiovascular Drugs | 2003 |
Cardiomyopathy Is Linked to Complement Activation
M Afanasyeva, NR Rose |
The American Journal of Pathology | 2002 |
C-reactive protein as a pro-inflammatory mediator in cardiovascular disease by its ability to activate complement: additional proof and hypothetical mechanisms
W K Lagrand, R Nijmeijer, H W M Niessen, C A Visser, W Th Hermens, C E Hack |
Netherlands Heart Journal | 2002 |
C1-Inhibitor Reduces the Ischaemia-Reperfusion Injury of Skeletal Muscles in Mice after Aortic Cross-Clamping: C1-INH Reduces IRI in Mice
EW Nielsen, TE Mollnes, JM Harlan, RK Winn |
Scandinavian Journal of Immunology | 2002 |
Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury
JE Jordan, MC Montalto, GL Stahl |
Circulation | 2001 |
Complement and Polymorphonuclear Leukocyte Activation Each Play a Role in Determining Myocardial Ischemia - Reperfusion Injury
T Atsuumi, H Yaoita, T Shichishima, K Maehara, T Fujita, Y Maruyama |
Japanese Circulation Journal | 2001 |
Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement
T Monsinjon, V Richard, M Fontaine |
Fundamental and Clinical Pharmacology | 2001 |
Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver
L Bergamaschini, G Gobbo, S Gatti, L Caccamo, P Prato, M Maggioni, P Braidotti, RD Stefano, LR Fassati |
Clinical & Experimental Immunology | 2001 |
CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?
R Nijmeijer, WK Lagrand, CA Visser, CJ Meijer, HW Niessen, CE Hack |
International Immunopharmacology | 2001 |
Immunostaining by Complement C9: A Tool for Early Diagnosis of Myocardial Infarction and Application in Forensic Medicine
MD Piercecchi-Marti, H Lepidi, G Leonetti, O Vire, F Cianfarani, JF Pellissier |
Journal of Forensic Sciences | 2001 |
The Role of the Complement Cascade in Ischemia/Reperfusion Injury: Implications for Neuroprotection
AL DAmbrosio, DJ Pinsky, ES Connolly |
Molecular Medicine | 2001 |
Role of the Complement System in Ischaemic Heart Disease: Potential for Pharmacological Intervention
SK Shernan, CD Collard |
BioDrugs | 2001 |
Complement activation after oxidative stress: role of the lectin complement pathway
CD Collard, A Väkevä, MA Morrissey, A Agah, SA Rollins, WR Reenstra, JA Buras, S Meri, GL Stahl |
The American Journal of Pathology | 2000 |
Complement activation induced by ischemia-reperfusion in humans: a study in patients undergoing partial hepatectomy
IH Straatsburg, MA Boermeester, GJ Wolbink, TM Gulik, DJ Gouma, WM Frederiks, CE Hack |
Journal of Hepatology | 2000 |
Reduction of myocardial infarct size with sCR1sLex, an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x
K Zacharowski, M Otto, G Hafner, HC Marsh, C Thiemermann |
British Journal of Pharmacology | 1999 |
Complement activation following oxidative stress
CD Collard, R Lekowski, JE Jordan, A Agah, GL Stahl |
Molecular Immunology | 1999 |
Strategies for targeting complement inhibitors in ischaemia/reperfusion injury
J Dong, JR Pratt, RA Smith, I Dodd, SH Sacks |
Molecular Immunology | 1999 |
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction
M Griselli, J Herbert, WL Hutchinson, KM Taylor, M Sohail, T Krausz, MB Pepys |
Journal of Experimental Medicine | 1999 |
Endothelin-1 is involved in plasma mediated stimulation of neutrophil adherence during coronary artery bypass grafting
P Bugajski |
European Journal of Cardio-Thoracic Surgery | 1999 |
Complement depletion does not reduce brain injury in a rabbit model of thromboembolic stroke
SM Lew, CE Gross, MM Bednar, SJ Russell, SP Fuller, CL Ellenberger, D Howard |
Brain Research Bulletin | 1999 |
C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial Infarction
M Griselli, J Herbert, WL Hutchinson, KM Taylor, M Sohail, T Krausz, MB Pepys |
Journal of Experimental Medicine | 1999 |
Yearbook of Intensive Care and Emergency Medicine 1999
JL Vincent |
1999 | |
Complement activation and regulator expression after anoxic injury of human endothelial cells
A Väkevä, S Meri |
APMIS | 1998 |
Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion : Role of the Terminal Complement Components and Inhibition by Anti-C5 Therapy
AP Vakeva, A Agah, SA Rollins, LA Matis, L Li, GL Stahl |
Circulation | 1998 |
Human Heart Generates Complement Proteins That Are Upregulated and Activated After Myocardial Infarction
K Yasojima, C Schwab, EG McGeer, PL McGeer |
Circulation research | 1998 |
Activation of complement by tissue plasminogen activator, but not acute cerebral ischemia, in a rabbit model of thromboembolic stroke
MM Bednar, CE Gross, SR Russell, D Short, PC Giclas |
Journal of Neurosurgery | 1997 |
Streptokinase, complement activation and hypotension
A Pachaïi, AK Erlendsson, I Brandslund |
APMIS | 1997 |
COMPLEMENT ACTIVATION AS A CAUSE FOR PRIMARY GRAFT FAILURE IN AN ISOGENEIC RAT MODEL OF HYPOTHERMIC LUNG PRESERVATION AND TRANSPLANTATION
Y Naka, HC Marsh, SM Scesney, MC Oz, DJ Pinsky |
Transplantation | 1997 |
Dynamic extracellular matrix remodeling in the heart failure: cardiac hypertrophy, dilatation and fibrosis
SC Tyagi |
Pathophysiology | 1997 |
Reoxygenation of Hypoxic Human Umbilical Vein Endothelial Cells Activates the Classic Complement Pathway
CD Collard, A Väkevä, C Büküsoglu, G Zünd, CJ Sperati, SP Colgan, GL Stahl |
Circulation | 1997 |
Forschung in der Chirurgie
HG Berger, A Schwarz, UB Brückner, W Hartel |
1997 | |
Sialic acids in molecular and cellular interactions
S Kelm, R Schauer |
International Review of Cytology | 1997 |
Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.
Tada T, Okada H, Okada N, Tateyama H, Suzuki H, Takahashi Y, Eimoto T |
Virchows Archiv : an international journal of pathology | 1997 |
Protective effect of methionine in the ischemia-reperfusion cardiac injury in the canine model
K Prasad, D Debnath, J Kalra, M Prasad |
International Journal of Angiology | 1996 |
Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells
SC Tyagi, SK G., SR Alla, HK Reddy, DJ Voelker, JS Janicki |
Journal of Cellular Physiology | 1996 |
Reduction-oxidation (redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells
SC Tyagi, SK G., S Borders |
Journal of Cellular Biochemistry | 1996 |
Immunological characterization and functional importance of human heart mast cells
G Marone, G Crescenzo, M Adt, V Patella, E Arbustini, A Genovese |
Immunopharmacology | 1995 |
Activation of the terminal complement cascade in renal infarction
A Väkevä, S Meri, T Lehto, P Laurila |
Kidney International | 1995 |
Immunohistochemical detection of C5b-9(m) in myocardium: an aid in distinguishing infarction-induced ischemic heart muscle necrosis from other forms of lethal myocardial injury
H Thomsen, H Held |
Forensic Science International | 1995 |
Nitric Oxide
RA Schroeder, PC Kuo |
Anesthesia & Analgesia | 1995 |
Complement system in coronary heart disease: a review
M Gardinali, L Conciato, C Cafaro, A Agostoni |
Immunopharmacology | 1995 |
Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium
A Väkevä, BP Morgan, I Tikkanen, K Helin, P Laurila, S Meri |
The American Journal of Pathology | 1994 |
Platelet-activating factor (PAF): Implications for coronary heart and vascular diseases
AM Evangelou |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1994 |
Practical Peripheral Arterial Thrombolysis
JJ Earnshaw |
Practical Peripheral Arterial Thrombolysis | 1994 |
Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion
RD Rossen, LH Michael, HK Hawkins, K Youker, WJ Dreyer, RE Baughn, ML Entman |
Circulation research | 1994 |
Membrane Biogenesis
AH Maddy, JR Harris |
Membrane Biogenesis | 1994 |
Pathophysiology and Mediators of Ischemia-Reperfusion Injury with Special Reference to Cardiac Surgery: A Review
J Vaage, G Valen |
Scandinavian Cardiovascular Journal | 1993 |
Perfluorochemical reperfusion yields improved myocardial recovery after global ischemia
SM Martin, H Laks, DC Drinkwater, DG Stein, ER Capouya, JM Pearl, SW Barthel, P Chang, E Kaczer, S Bhuta |
The Annals of Thoracic Surgery | 1993 |
Regulation of complement membrane attack complex formation in myocardial infarction
A Väkevä, P Laurila, S Meri |
The American Journal of Pathology | 1993 |
Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction
A Väkevä, P Laurila, S Meri |
Immunology | 1993 |
Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730)
EF Smith, DE Griswold, JW Egan, LM Hillegass, RA Smith, MJ Hibbs, RC Gagnon |
European Journal of Pharmacology | 1993 |
Neutrophil adherence-augmenting and chemotactic plasma activities in acute myocardial infarction: effect of fibrynolytic treatment
R Klimas, T Siminiak, H Wysocki |
International Journal of Cardiology | 1993 |
Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury
SM Shandelya, P Kuppusamy, A Herskowitz, ML Weisfeldt, JL Zweier |
Circulation | 1993 |
Interleukin-8 is not involved in the increased chemotactic activity of peripheral blood plasma during acute myocardial infarction
T Siminiak, J M Schröder, M Sticherling, H Wysocki |
Basic Research in Cardiology | 1993 |
Activated neutrophils impair rabbit heart recovery after hypothermic global ischemia
ML Myers, C Webb, M Moffat, D McIver, RD Maestro |
The Annals of Thoracic Surgery | 1992 |
Perfluorochemical Reperfusion Limits Myocardial Reperfusion Injury After Prolonged Hypothermic Global Ischemia
SM Martin, H Laks, DC Drinkwater, DG Stein, SW Barthel, ER Capouya, JM Pearl, S Bhuta, B Ho, P Chang |
Artificial Cells, Blood Substitutes and Biotechnology | 1992 |
Neutrophil infiltration into the ischaemic/reperfused rabbit isolated myocardium: effect of PF-5901 and cycloheximide
N Lad, TJ Williams, RF Booth |
European Journal of Pharmacology | 1992 |
Neutrophils as mediators of human skeletal muscle ischemia-reperfusion syndrome
L Formigli, LD Lombardo, C Adembri, S Brunelleschi, E Ferrari, GP Novelli |
Human Pathology | 1992 |
The Complement System
A Agostoni, M Cicardi, M Gardinali, L Bergamaschini |
International journal of immunopathology and pharmacology | 1992 |
Effects of complement activation in the isolated heart. Role of the terminal complement components
JW Homeister, P Satoh, BR Lucchesi |
Circulation research | 1992 |
The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivo
WA Schumacher, JC Fantone, SE Kunkel, RC Webb, BR Lucchesi |
Agents and Actions | 1991 |
Analysis of inflammatory cells and complement C3 in bupivacaine-induced myonecrosis
S Orimo, E Hiyamuta, K Arahata, H Sugita |
Muscle & Nerve | 1991 |
Pathophysiology of ischaemia reperfusion injury: Central role of the neutrophil
CR Welbourn, G Goldman, IS Paterson, CR Valeri, D Shepro, HB Hechtman |
British Journal of Surgery | 1991 |
Evaluation of thromboxane production and complement activation during myocardial ischemia in patients with angina pectoris
G Montalescot, G Drobinski, J Maclouf, F Maillet, J Salloum, A Ankri, M Kazatchkine, L Eugène, D Thomas, Y Grosgogeat |
Circulation | 1991 |
Coronary Trapping of a Complement Activation Product (C3a des-Arg) During Myocardial Reperfusion in Open-Heart Surgery
AG Semb, J Vaage, D Sørlie, M Lie, OD Mjøs |
Scandinavian Cardiovascular Journal | 1990 |
Complement Activation by Pulsed Tunable Dye Laser in Normal Skin and Hemangioma
F Gay-Crosier, LL Polla, J Tschopp, JA Schifferli |
Journal of Investigative Dermatology | 1990 |
Prostaglandins and extracorporeal circulation
MB Starling, JM Neutze |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1990 |
Leucocytes and cardiopulmonary bypass: in vitro production of oxygen free radicals and trapping in the reperfused myocardium
AG Semb, J Vaage, M Lie, D Sørlie, OD Mjøs |
Perfusion | 1990 |
Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs
BR Ito, DM Roth, RL Engler |
Circulation research | 1990 |
The complement system in ischemic heart disease
M Yasuda, K Takeuchi, M Hiruma, H Iida, A Tahara, H Itagane, I Toda, K Akioka, M Teragaki, H Oku |
Circulation | 1990 |
Role of thromboxane A2 in the cardiovascular response to intracoronary C5a
GL Stahl, EA Amsterdam, JD Symons, JC Longhurst |
Circulation research | 1990 |
Pathophysiology of Severe Ischemic Myocardial Injury
HM Piper |
1990 | |
The erythrocyte as instigator of inflammation. Generation of amidated C3 by erythrocyte adenosine deaminase
MK Hostetter, GM Johnson |
Journal of Clinical Investigation | 1989 |
Immunocytochemical diagnosis of early myocardial ischaemic/hypoxic damage
S Leadbeatter, HM Wawman, B Jasani |
Forensic Science International | 1989 |
Influence of leukopenia on collateral flow, reperfusion flow, reflow ventricular fibrillation, and infarct size in dogs
M Lorgeril, A Basmadjian, M Lavallèe, R Clément, D Millette, G Rousseau, JG Latour |
American Heart Journal | 1989 |
Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation
BR Ito, DM Roth, DE Chenoweth, AM Lefer, RL Engler |
Circulation research | 1989 |
Can superoxide dismutase alter myocardial infarct size?
R Engler, E Gilpin |
Circulation | 1989 |
Myocardial ischemia and reperfusion: The role of oxygen radicals in tissue injury
SW Werns, BR Lucchesi |
Cardiovascular Drugs and Therapy | 1989 |
Inheritance of Kidney and Urinary Tract Diseases
A Spitzer, ED Avner |
1989 | |
Prevention of reperfusion injury in the neonatal heart with leukocyte-depleted blood
MA Breda, DC Drinkwater, H Laks, S Bhuta, AF Como, HG Davtyan, P Chang |
The Journal of Thoracic and Cardiovascular Surgery | 1989 |
Detection of the terminal complement complex in patient plasma following acute myocardial infarction
PF Langlois, MS Gawryl |
Atherosclerosis | 1988 |
Activated Neutrophils Release Mediators That May Contribute to Myocardial Injury and Dysfunction Associated with Ischemia and Reperfusion
KM Mullane, W Westlin, R Kraemer |
Annals of the New York Academy of Sciences | 1988 |
Complement C5a (desArg) generation in serum exposed to damaged aortic endothelium
PS Seifert, JL Catalfamo, WJ Dodds |
Experimental and Molecular Pathology | 1988 |
Therapeutic Options to Minimize Free Radical Damage and Thrombogenicity in Ischemic/Reperfused Myocardium
SR Maza, WH Frishman |
Medical Clinics of North America | 1988 |
Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury
MH Crawford, FL Grover, WP Kolb, CA McMahan, RA O'Rourke, LM McManus, RN Pinckard |
Circulation | 1988 |
Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo
RD Rossen, LH Michael, A Kagiyama, HE Savage, G Hanson, MA Reisberg, JN Moake, SH Kim, D Self, S Weakley |
Circulation research | 1988 |
C5a decreases regional coronary blood flow and myocardial function in pigs: implications for a granulocyte mechanism
SE Martin, DE Chenoweth, RL Engler, DM Roth, JC Longhurst |
Circulation research | 1988 |
Mechanisms of Myocardial Ischemia and Infarction
PR Wolff, M Nugent |
Anesthesiology Clinics of North America | 1988 |
Effect of complement depletion on O2 supply and consumption in ischemic dog myocardium
GJ Grover, HR Weiss |
Basic Research in Cardiology | 1987 |
Activation of the complement system by recombinant tissue plasminogen activator
WR Bennett, DH Yawn, PJ Migliore, JB Young, CM Pratt, AE Raizner, R Roberts, R Bolli |
Journal of the American College of Cardiology | 1987 |
Presence of C5b-9 complement complex and S-protein in human myocardial areas with necrosis and sclerosis
HG Rus, F Niculescu, R Vlaicu |
Immunology Letters | 1987 |
Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation
PJ Simpson, SE Mitsos, A Ventura, KP Gallagher, JC Fantone, GD Abrams, MA Schork, BR Lucchesi |
American Heart Journal | 1987 |
Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion
P Chatelain, JG Latour, D Tran, M de Lorgeril, G Dupras, M Bourassa |
Circulation | 1987 |
Reduction of myocardial infarct size by neutrophil depletion: Effect of duration of occlusion
SR Jolly, WJ Kane, BG Hook, GD Abrams, SL Kunkel, BR Lucchesi |
American Heart Journal | 1986 |
The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis
JA Thompson, ML Hess |
Progress in Cardiovascular Diseases | 1986 |
Relation of early mononuclear and polymorphonuclear cell infiltration to late scar thickness after experimentally induced myocardial infarction in the rat
CS Roberts, D Maclean, P Maroko, RA Kloner |
Basic Research in Cardiology | 1985 |
Cardiac dysfunction caused by purified human C3a anaphylatoxin
UH Balzo, R Levi, MJ Polley |
Proceedings of the National Academy of Sciences | 1985 |
Platelet depletion in experimental myocardial infarction
SR Jolly, WA Schumacher, SL Kunkel, GD Abrams, J Liddicoat, BR Lucchesi |
Basic Research in Cardiology | 1985 |
Free radicals in ischemic myocardial injury
SW Werns, MJ Shea, BR Lucchesi |
Journal of Free Radicals in Biology & Medicine | 1985 |
Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardium
KM Mullane, R Kraemer, B Smith |
Journal of Pharmacological Methods | 1985 |
Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury
RD Rossen, JL Swain, LH Michael, S Weakley, E Giannini, ML Entman |
Circulation research | 1985 |
Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia
ML Myers, R Bolli, RF Lekich, CJ Hartley, R Roberts |
Circulation | 1985 |
The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase but not catalase
SW Werns, MJ Shea, EM Driscoll, C Cohen, GD Abrams, B Pitt, BR Lucchesi |
Circulation research | 1985 |
Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase
SR Jolly, WJ Kane, MB Bailie, GD Abrams, BR Lucchesi |
Circulation research | 1984 |
Ibuprofen inhibits granulocyte responses to inflammatory mediators: A proposed mechanism for reduction of experimental myocardial infarct size
PJ Flynn, WK Becker, GM Vercellotti, DJ Weisdorf, PR Craddock, DE Hammerschmidt, RC Lillehei, HS Jacob |
Inflammation | 1984 |
Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog
JL Romson, BG Hook, SL Kunkel, GD Abrams, MA Schork, BR Lucchesi |
Circulation | 1983 |
THERAPEUTIC RAMIFICATIONS OF THE INTERACTION OF COMPLEMENT, GRANULOCYTES, AND PLATELETS IN THE PRODUCTION OF ACUTE LUNG INJURY
HS Jacob, CF Moldow, PJ Flynn, DJ Weisdorf, GM Vercellotti, DE Hammerschmidt |
Annals of the New York Academy of Sciences | 1982 |
Complement activation in muscle fiber necrosis: Demonstration of the membrane attack complex of complement in necrotic fibers
AG Engel, G Biesecker |
Annals of Neurology | 1982 |
Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis
G Biesecker, S Katz, D Koffler |
Journal of Experimental Medicine | 1981 |
Characterization of the binding of purified human C1q to heart mitochondrial membranes
SB Storrs, WP Kolb, RN Pinckard, MS Olson |
The Journal of biological chemistry | 1981 |